Biofrontera (BFRIW) Competitors $0.10 0.00 (-0.10%) As of 09/24/2025 09:30 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsShort InterestTrendsBuy This Stock BFRIW vs. ATNFW, LBPSW, AIMDW, ALVOW, ACABW, BTMDW, BCTXW, CALA, CELUW, and CINGWShould you be buying Biofrontera stock or one of its competitors? The main competitors of Biofrontera include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), biote (BTMDW), BriaCell Therapeutics (BCTXW), Calithera Biosciences (CALA), Celularity (CELUW), and Cingulate (CINGW). These companies are all part of the "pharmaceutical products" industry. Biofrontera vs. Its Competitors 180 Life Sciences 4D pharma Ainos Alvotech Atlantic Coastal Acquisition Corp. II biote BriaCell Therapeutics Calithera Biosciences Celularity Cingulate Biofrontera (NASDAQ:BFRIW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, media sentiment, earnings, dividends, analyst recommendations, risk, valuation and institutional ownership. Does the media refer more to BFRIW or ATNFW? In the previous week, Biofrontera had 1 more articles in the media than 180 Life Sciences. MarketBeat recorded 1 mentions for Biofrontera and 0 mentions for 180 Life Sciences. Biofrontera's average media sentiment score of 0.00 equaled 180 Life Sciences'average media sentiment score. Company Overall Sentiment Biofrontera Neutral 180 Life Sciences Neutral Is BFRIW or ATNFW more profitable? Company Net Margins Return on Equity Return on Assets BiofronteraN/A N/A N/A 180 Life Sciences N/A N/A N/A Which has better earnings and valuation, BFRIW or ATNFW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBiofrontera$39.19MN/AN/AN/AN/A180 Life SciencesN/AN/AN/AN/AN/A SummaryBiofrontera beats 180 Life Sciences on 2 of the 2 factors compared between the two stocks. Get Biofrontera News Delivered to You Automatically Sign up to receive the latest news and ratings for BFRIW and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BFRIW vs. The Competition Export to ExcelMetricBiofronteraDrug Manufacturers IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$1.60B$5.77B$10.42BDividend YieldN/A2.94%5.68%4.62%P/E RatioN/A68.7676.2826.42Price / SalesN/A1,629.93553.28128.19Price / CashN/A10.3737.5661.52Price / BookN/A11.3713.186.39Net IncomeN/A$20.70B$3.29B$271.13M7 Day Performance-5.34%0.65%0.84%0.93%1 Month PerformanceN/A0.80%5.03%7.52%1 Year PerformanceN/A5.59%71.27%30.06% Biofrontera Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BFRIWBiofronteraN/A$0.10-0.1%N/A+159.0%$0.00$39.19M0.0070Positive NewsGap DownATNFW180 Life SciencesN/A$0.07-1.5%N/A+843.0%$0.00N/A0.007Gap UpLBPSW4D pharmaN/AN/AN/AN/A$0.00$522K0.00N/AAIMDWAinosN/A$0.16+6.6%N/AN/A$0.00$110.87K0.0040Gap UpALVOWAlvotechN/A$1.09+5.5%N/A-37.9%$0.00$560.10M0.004Gap DownACABWAtlantic Coastal Acquisition Corp. IIN/A$0.05flatN/A-21.1%$0.00N/A0.0015Gap UpBTMDWbioteN/A$0.01+16.3%N/AN/A$0.00$199.07M0.00N/AGap DownBCTXWBriaCell TherapeuticsN/A$0.03-2.3%N/A-90.0%$0.00N/A0.008Gap DownCALACalithera BiosciencesN/AN/AN/A-90.0%$0.00N/A0.0060CELUWCelularityN/A$0.05+11.9%N/AN/A$0.00$44.59M0.00220Positive NewsGap DownCINGWCingulateN/A$0.05+0.6%N/A-28.5%$0.00N/A0.0020Gap Down Related Companies and Tools Related Companies 180 Life Sciences Competitors 4D pharma Competitors Ainos Competitors Alvotech Competitors Atlantic Coastal Acquisition Corp. II Competitors biote Competitors BriaCell Therapeutics Competitors Calithera Biosciences Competitors Celularity Competitors Cingulate Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BFRIW) was last updated on 9/25/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biofrontera Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biofrontera With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
